Antipsychotic prescribing: do conflict of interest policies make a difference?

Medical Care
Timothy S AndersonJulie M Donohue

Abstract

Academic medical centers (AMCs) have increasingly adopted conflict of interest policies governing physician-industry relationships; it is unclear how policies impact prescribing. To determine whether 9 American Association of Medical Colleges (AAMC)-recommended policies influence psychiatrists' antipsychotic prescribing and compare prescribing between academic and nonacademic psychiatrists. We measured number of prescriptions for 10 heavily promoted and 9 newly introduced/reformulated antipsychotics between 2008 and 2011 among 2464 academic psychiatrists at 101 AMCs and 11,201 nonacademic psychiatrists. We measured AMC compliance with 9 AAMC recommendations. Difference-in-difference analyses compared changes in antipsychotic prescribing between 2008 and 2011 among psychiatrists in AMCs compliant with ≥ 7/9 recommendations, those whose institutions had lesser compliance, and nonacademic psychiatrists. Ten centers were AAMC compliant in 2008, 30 attained compliance by 2011, and 61 were never compliant. Share of prescriptions for heavily promoted antipsychotics was stable and comparable between academic and nonacademic psychiatrists (63.0%-65.8% in 2008 and 62.7%-64.4% in 2011). Psychiatrists in AAMC-compliant centers were slightl...Continue Reading

References

Feb 15, 2002·The New England Journal of Medicine·Meredith B RosenthalArnold M Epstein
Jul 10, 2003·JAMA : the Journal of the American Medical Association·Jason Dana, George Loewenstein
Sep 10, 2005·Journal of Psychiatric Research·Jennifer HoblynHelena C Kraemer
Sep 21, 2005·The New England Journal of Medicine·Jeffrey A LiebermanUNKNOWN Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Investigators
May 6, 2006·Psychiatric Services : a Journal of the American Psychiatric Association·Johannes HamannWerner Kissling
Aug 8, 2007·Archives of General Psychiatry·Rajiv TandonJohn M Davis
Mar 4, 2008·BMJ : British Medical Journal·Thomas P Stossel
Sep 3, 2009·Psychiatric Services : a Journal of the American Psychiatric Association·Douglas L LeslieRobert A Rosenheck
Dec 10, 2009·JAMA : the Journal of the American Medical Association·David J NyweideElliott S Fisher
Jan 22, 2011·Pharmacoepidemiology and Drug Safety·G C AlexanderR S Stafford
Mar 30, 2011·Archives of Internal Medicine·David Michael Freshwater, M Felix Freshwater
May 4, 2012·Pharmacoepidemiology and Drug Safety·Stacie B DusetzinaHaiden A Huskamp
Jan 3, 2013·Psychiatric Services : a Journal of the American Psychiatric Association·Haiden A HuskampJulie M Donohue
Feb 28, 2013·Journal of General Internal Medicine·Kirsten E AustadAaron S Kesselheim
Mar 8, 2013·PloS One·Rachel KornfieldG Caleb Alexander
Aug 24, 2013·Academic Medicine : Journal of the Association of American Medical Colleges·Susan ChimonasDavid J Rothman
Dec 12, 2013·JAMA : the Journal of the American Medical Association·David Korn, Daniel Carlat
Dec 18, 2013·Psychiatric Services : a Journal of the American Psychiatric Association·Julie DonohueHaiden A Huskamp
Oct 1, 2014·JAMA : the Journal of the American Medical Association·Tammy C HoffmannChris Del Mar

❮ Previous
Next ❯

Software Mentioned

SAS

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here